• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于定量原料药和注射剂型中盐酸拓扑替康的反相超高效液相色谱法的开发与验证

Development and Validation of a RP-Ultra performance liquid chromatographic Method for Quantification of Topotecan Hydrochloride in Bulk and Injection Dosage Form.

作者信息

Saini P K, Jain C L, Singh R M, Mathur S C, Singh G N

机构信息

Research and Development Division, Indian Pharmacopoeia Commission, Sector-23, Rajnagar Ghaziabad-201 001, India.

出版信息

Indian J Pharm Sci. 2010 Jul;72(4):494-7. doi: 10.4103/0250-474X.73925.

DOI:10.4103/0250-474X.73925
PMID:21218062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3013564/
Abstract

A simple, very fast, precise and accurate reverse phase ultra performance liquid chromatographic method was developed for the determination and validation of topotecan hydrochloride in bulk and injection dosage form. A Waters BEH C18, 50×2.1 mm, 1.7 μm particle size column in gradient mode was used with mobile phase comprising of 0.1% v/v orthophosphoric acid in water and acetonitrile. The analytical column was thermostated at 50° and flow rate was set at 0.4 ml per min, with photo diode array detection at 260 nm. The retention time of topotecan was found 1.38 min. The method was validated in terms of linearity, accuracy, precision and specificity. The calibration curve was found linear between 20 to 60 μg/ml. The limit of detection and limit of quantification were found 0.2353 and 0.7131 μg/ml, respectively. Percentage recoveries were obtained in the range of 98.91% and 99.17%. The proposed method is precise, accurate, selective and reproducible. The ultra performance liquid chromatographic assay procedure, which proved superior because of its greater sensitivity and relatively shorter (4 min) run time, should be an important tool for speedy future analysis of topotecan hydrochloride in bulk and its injection dosage form.

摘要

建立了一种简单、快速、精确且准确的反相超高效液相色谱法,用于测定和验证原料药及注射剂剂型中的盐酸拓扑替康。采用Waters BEH C18柱(50×2.1 mm,粒径1.7μm),以梯度模式运行,流动相由0.1%(v/v)的磷酸水溶液和乙腈组成。分析柱温度设定为50℃,流速设定为每分钟0.4 ml,采用光电二极管阵列检测器,检测波长为260 nm。测得盐酸拓扑替康的保留时间为1.38分钟。该方法在线性、准确度、精密度和特异性方面均得到验证。校准曲线在20至60μg/ml范围内呈线性。检测限和定量限分别为0.2353和0.7131μg/ml。回收率在98.91%至99.17%之间。所提出的方法精确、准确、具有选择性且可重现。超高效液相色谱测定法因其更高的灵敏度和相对较短(4分钟)的运行时间而表现出色,应成为未来快速分析盐酸拓扑替康原料药及其注射剂剂型的重要工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7262/3013564/2a6b63a928c6/IJPhS-72-494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7262/3013564/2a6b63a928c6/IJPhS-72-494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7262/3013564/2a6b63a928c6/IJPhS-72-494-g001.jpg

相似文献

1
Development and Validation of a RP-Ultra performance liquid chromatographic Method for Quantification of Topotecan Hydrochloride in Bulk and Injection Dosage Form.一种用于定量原料药和注射剂型中盐酸拓扑替康的反相超高效液相色谱法的开发与验证
Indian J Pharm Sci. 2010 Jul;72(4):494-7. doi: 10.4103/0250-474X.73925.
2
Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form.盐酸文拉法辛原料药及胶囊剂型的超高效液相色谱法的开发与验证
Indian J Pharm Sci. 2010 Nov;72(6):814-8. doi: 10.4103/0250-474X.84605.
3
Development and Validation of a Rapid RP-UPLC Method for the Simultaneous Estimation of Bambuterol Hydrochloride and Montelukast Sodium from Tablets.一种用于同时测定片剂中盐酸班布特罗和孟鲁司特钠的快速反相超高效液相色谱法的开发与验证
Indian J Pharm Sci. 2012 Mar;74(2):116-21. doi: 10.4103/0250-474X.103841.
4
Analytical method development and validation of prasugrel in bulk and its pharmaceutical formulation using the RP-HPLC method.采用反相高效液相色谱法(RP-HPLC)对普拉格雷原料药及其药物制剂进行分析方法的开发与验证。
Pharm Methods. 2011 Jul;2(3):173-7. doi: 10.4103/2229-4708.90357.
5
Development and validation of a liquid chromatographic method for estimation of dicyclomine hydrochloride, mefenamic Acid and paracetamol in tablets.一种用于测定片剂中盐酸双环胺、甲芬那酸和对乙酰氨基酚的液相色谱方法的开发与验证
Indian J Pharm Sci. 2014 Nov-Dec;76(6):529-34.
6
A Validated Reverse Phase-Ultra-Performance Liquid Chromatography Method for the Determination of Gemifloxacin Mesylate in Bulk and its Pharmaceutical Preparation.一种验证过的反相超高效液相色谱法用于测定原料药及制剂中的甲磺酸吉米沙星
Turk J Pharm Sci. 2019 Mar;16(1):8-13. doi: 10.4274/tjps.04934. Epub 2018 Dec 31.
7
UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.超高效液相色谱法(UPLC)和液相色谱 - 质谱联用(LC - MS)对盐酸伊立替康降解行为的研究以及开发一种经验证的稳定性指示超高效液相色谱法,用于测定药物剂型中盐酸伊立替康及其杂质。
J Chromatogr Sci. 2012 Oct;50(9):810-9. doi: 10.1093/chromsci/bms075. Epub 2012 Jun 1.
8
RP-HPLC Estimation of Venlafaxine Hydrochloride in Tablet Dosage Forms.反相高效液相色谱法测定片剂剂型中盐酸文拉法辛的含量
Indian J Pharm Sci. 2008 Jan;70(1):124-8. doi: 10.4103/0250-474X.40350.
9
A Chromatographic Determination of Aripiprazole using HPLC and UPLC: A Comparative Validation Study.使用高效液相色谱法(HPLC)和超高效液相色谱法(UPLC)对阿立哌唑进行色谱测定:一项比较验证研究。
Indian J Pharm Sci. 2011 Jul;73(4):439-43. doi: 10.4103/0250-474X.95638.
10
Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms.反相高效液相色谱法同时测定原料药和片剂剂型中阿巴卡韦和拉米夫定的分析方法开发与验证
Pharmacognosy Res. 2018 Jan-Mar;10(1):92-97. doi: 10.4103/pr.pr_96_17.

本文引用的文献

1
Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography.采用反相高效液相色谱法测定人及小鼠血浆和小鼠组织匀浆中的拓扑替康。
Biomed Chromatogr. 2007 Nov;21(11):1191-200. doi: 10.1002/bmc.874.
2
Simple and sensitive high performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of topotecan in human plasma.一种简单且灵敏的高效液相色谱法,用于同时定量测定人血浆中拓扑替康的内酯形式和羧酸盐形式。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Apr 25;818(2):205-12. doi: 10.1016/j.jchromb.2004.12.027.
3
Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detection.
采用反相液相色谱-荧光检测法测定血浆中拓扑替康及其代谢物N-去甲基拓扑替康的内酯型和总型。
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 5;784(2):225-32. doi: 10.1016/s1570-0232(02)00798-5.
4
Urinary and fecal excretion of topotecan in patients with malignant solid tumours.拓扑替康在恶性实体瘤患者中的尿排泄和粪排泄情况。
Cancer Chemother Pharmacol. 2002 Jul;50(1):59-64. doi: 10.1007/s00280-002-0454-2. Epub 2002 Apr 5.
5
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.喜树碱类药物的临床经验、药理学及持续研发的当前观点。
Clin Cancer Res. 2002 Mar;8(3):641-61.
6
A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.拓扑替康用于宫颈癌鳞状细胞癌患者的II期研究:一项妇科肿瘤学组研究。
Gynecol Oncol. 2001 May;81(2):213-5. doi: 10.1006/gyno.2000.6024.
7
Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues.拓扑替康对拓扑异构酶I的抑制作用:药理学及临床问题
Expert Opin Pharmacother. 2001 Mar;2(3):491-505. doi: 10.1517/14656566.2.3.491.
8
Determination of topotecan by ELISA.采用酶联免疫吸附测定法测定拓扑替康。
Biol Pharm Bull. 2001 Apr;24(4):321-6. doi: 10.1248/bpb.24.321.
9
An overview of topoisomerase I-targeting agents.靶向拓扑异构酶I药物概述。
Semin Hematol. 1998 Jul;35(3 Suppl 4):3-12.
10
Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors.喜树碱拓扑异构酶I抑制剂的临床药代动力学
Pharm World Sci. 1998 Aug;20(4):161-72. doi: 10.1023/a:1008613806051.